Kestra Private Wealth Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Kestra Private Wealth Services's FBT Position: Q1 2026 in Review
Kestra Private Wealth Services reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.1% in Q1 2026, selling an estimated $130K and leaving 8,290 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #616.
Kestra Private Wealth Services first reported a position in FBT in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.06M in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Kestra Private Wealth Services held 8,290 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.66M as of Q1 2026.
- Kestra Private Wealth Services sold 629 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $130K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Kestra Private Wealth Services's portfolio in Q1 2026, its #616 holding.
- Kestra Private Wealth Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2020 and has held it in 23 quarters since.
- Kestra Private Wealth Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.06M in Q4 2020.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.